Cargando…

Nepalese patients’ perceptions of treatment modalities for type 2 diabetes

BACKGROUND: Perceptions and beliefs about treatment can influence patients’ adherence to treatment regimens. Perceptions, in turn, are often shaped by patients’ sociocultural context. Nepal and the Nepalese have unique sociocultural traditions and beliefs, and their perceptions of diabetes treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapkota, Sujata, Brien, Jo-anne E, Aslani, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028164/
https://www.ncbi.nlm.nih.gov/pubmed/27695296
http://dx.doi.org/10.2147/PPA.S113467
_version_ 1782454341046632448
author Sapkota, Sujata
Brien, Jo-anne E
Aslani, Parisa
author_facet Sapkota, Sujata
Brien, Jo-anne E
Aslani, Parisa
author_sort Sapkota, Sujata
collection PubMed
description BACKGROUND: Perceptions and beliefs about treatment can influence patients’ adherence to treatment regimens. Perceptions, in turn, are often shaped by patients’ sociocultural context. Nepal and the Nepalese have unique sociocultural traditions and beliefs, and their perceptions of diabetes treatment remain largely unexplored. This study explored Nepalese participants’ perceptions of diabetes treatment, and whether perceptions differed between the Nepalese living in Australia and Nepal. METHODS: Face-to-face qualitative interviews (n=48) were conducted with Nepalese participants with type 2 diabetes in Sydney and Kathmandu. All interviews were audio-recorded, transcribed verbatim, and thematically analyzed. RESULTS: Perceptions of diabetes treatment were similar among Nepalese participants in Australia and Nepal. There was a general reluctance to start oral antidiabetic medications and an even greater reluctance to commence parenteral (insulin) therapy. Participants preferred to try lifestyle modifications and alternative treatments such as herbs and “traditional” medicines, particularly as a first step. Unwillingness to take medications was primarily associated with the belief that, once started, these medications needed to be taken for life, and perceptions of long-term harms caused by such medications. Even when commenced on medication, participants were averse to any type of therapy escalation, for example, moving to insulin therapy. Insulin was perceived as the “last option” available for diabetes treatment. Most participants, however, did not find medication taking challenging once they had commenced treatment. CONCLUSION: Antidiabetic medications were perceived to be harmful and unstoppable once initiated. These perceptions significantly impacted participants’ willingness to commence antidiabetic medications and therefore have the potential to adversely affect their medication-taking behavior. This study therefore highlights the need to explore the impact of these perceptions on participants’ medication-taking behavior, and the need to address patients’ views of “modern” (commonly prescribed) and “traditional” (natural) medications through information and education, to ensure increased understanding of how medications are used for diabetes management.
format Online
Article
Text
id pubmed-5028164
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50281642016-09-30 Nepalese patients’ perceptions of treatment modalities for type 2 diabetes Sapkota, Sujata Brien, Jo-anne E Aslani, Parisa Patient Prefer Adherence Original Research BACKGROUND: Perceptions and beliefs about treatment can influence patients’ adherence to treatment regimens. Perceptions, in turn, are often shaped by patients’ sociocultural context. Nepal and the Nepalese have unique sociocultural traditions and beliefs, and their perceptions of diabetes treatment remain largely unexplored. This study explored Nepalese participants’ perceptions of diabetes treatment, and whether perceptions differed between the Nepalese living in Australia and Nepal. METHODS: Face-to-face qualitative interviews (n=48) were conducted with Nepalese participants with type 2 diabetes in Sydney and Kathmandu. All interviews were audio-recorded, transcribed verbatim, and thematically analyzed. RESULTS: Perceptions of diabetes treatment were similar among Nepalese participants in Australia and Nepal. There was a general reluctance to start oral antidiabetic medications and an even greater reluctance to commence parenteral (insulin) therapy. Participants preferred to try lifestyle modifications and alternative treatments such as herbs and “traditional” medicines, particularly as a first step. Unwillingness to take medications was primarily associated with the belief that, once started, these medications needed to be taken for life, and perceptions of long-term harms caused by such medications. Even when commenced on medication, participants were averse to any type of therapy escalation, for example, moving to insulin therapy. Insulin was perceived as the “last option” available for diabetes treatment. Most participants, however, did not find medication taking challenging once they had commenced treatment. CONCLUSION: Antidiabetic medications were perceived to be harmful and unstoppable once initiated. These perceptions significantly impacted participants’ willingness to commence antidiabetic medications and therefore have the potential to adversely affect their medication-taking behavior. This study therefore highlights the need to explore the impact of these perceptions on participants’ medication-taking behavior, and the need to address patients’ views of “modern” (commonly prescribed) and “traditional” (natural) medications through information and education, to ensure increased understanding of how medications are used for diabetes management. Dove Medical Press 2016-09-13 /pmc/articles/PMC5028164/ /pubmed/27695296 http://dx.doi.org/10.2147/PPA.S113467 Text en © 2016 Sapkota et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sapkota, Sujata
Brien, Jo-anne E
Aslani, Parisa
Nepalese patients’ perceptions of treatment modalities for type 2 diabetes
title Nepalese patients’ perceptions of treatment modalities for type 2 diabetes
title_full Nepalese patients’ perceptions of treatment modalities for type 2 diabetes
title_fullStr Nepalese patients’ perceptions of treatment modalities for type 2 diabetes
title_full_unstemmed Nepalese patients’ perceptions of treatment modalities for type 2 diabetes
title_short Nepalese patients’ perceptions of treatment modalities for type 2 diabetes
title_sort nepalese patients’ perceptions of treatment modalities for type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028164/
https://www.ncbi.nlm.nih.gov/pubmed/27695296
http://dx.doi.org/10.2147/PPA.S113467
work_keys_str_mv AT sapkotasujata nepalesepatientsperceptionsoftreatmentmodalitiesfortype2diabetes
AT brienjoannee nepalesepatientsperceptionsoftreatmentmodalitiesfortype2diabetes
AT aslaniparisa nepalesepatientsperceptionsoftreatmentmodalitiesfortype2diabetes